Cancer diagnosis in Brazil in the COVID-19 era
- 1 April 2021
- journal article
- review article
- Published by Elsevier in Seminars in Oncology
- Vol. 48 (2) , 156-159
Abstract
No abstract availableKeywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
This publication has 20 references indexed in Scilit:
- A country level analysis measuring the impact of government actions, country preparedness and socioeconomic factors on COVID-19 mortality and related health outcomeseClinicalMedicine, 2020
- Reduced demand for oral diagnosis during COVID‐19: A Brazilian center experienceOral Diseases, 2020
- Cancer diagnostic rates during the 2020 ‘lockdown’, due to COVID-19 pandemic, compared with the 2018–2019: an audit study from cellular pathologyJournal of Clinical Pathology, 2020
- Implication of COVID‐19 in oral oncology practices in Brazil, Canada, and the United StatesOral Diseases, 2020
- Management of cervical cancer patients during the COVID-19 pandemic: a challenge for developing countriesecancermedicalscience, 2020
- Coronavirus Disease Pandemic Is a Real Challenge for BrazilFrontiers in Public Health, 2020
- Early impact of the COVID-19 pandemic on paediatric cancer care in Latin AmericaThe Lancet Oncology, 2020
- A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative GroupThe Oncologist, 2020
- COVID-19 and Italy: what next?The Lancet, 2020
- Brazil's endangered postgraduate systemScience, 2019